tech
December 10, 2025
After Neuralink, Max Hodak is building something even wilder
"You could really, in a very fundamental sense, talk about redrawing the border around a brain," Hodak says, "possibly to include four hemispheres, or a device, or a whole group of people."
TL;DR
- Max Hodak, formerly of Neuralink, founded Science Corp with a focus on brain-computer interface (BCI) technology.
- Science Corp's first product is Prima, a retinal implant that restores vision to patients with macular degeneration.
- The company is developing optogenetic gene therapy to make neurons light-sensitive and exploring methods to grow new brain tissue.
- Hodak views BCI as a longevity-adjacent technology and believes the ultimate goal is to engineer consciousness.
- He envisions a future where consciousness could span multiple substrates, bodies, and minds, potentially leading to profound societal changes.
- Science Corp has secured $260 million in funding and is developing tools for researchers while pursuing its long-term goals.
- Hodak predicts biohybrid neural interfaces will be available for patients by 2035, becoming ubiquitous by the late 2040s.
- The proliferation of BCI technology may fundamentally alter healthcare economics and create cognitive inequalities.
Continue reading
the original article